Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...

Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026: Basel Saturday, May 2, 2026, 10:00 Hrs [IST] Roche announced that it will sho ...

Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...

Be proactive about your health Health screenings — physical exams, tests and procedures used to detect disease early — are important. Screening tests are designed to detect hidden disease ...

An investigative team evaluated the real-world performance of faricimab in managing patients with AMD and subretinal ...

Safety signals with faricimab in routine practice, including intraocular inflammation and endophthalmitis, aligned with prior ...

A wireless brain implant designed to restore artificial vision has been successfully implanted in ...

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...

Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...

“Glow” skin-care treatments have skyrocketed in popularity thanks to the promise of a more youthful look. More recently the trend has morphed with another craze — injectable peptides — to create ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...